Medifast, Inc.’s (MED) share price has entered into oversold territory with a stochastic value of 9.776. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 7 cents over the past two months to $1.45 per share. Medifast, Inc. is a Zacks #1 Rank (“Strong Buy”) company.
MEDIFAST INC (MED): Free Stock Analysis Report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment